Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - April 2001

  1. Providers debate pros and cons of pneumonia vaccination at discharge  Clin.Resour.Manag.  2001, 2 (2): 29-31,  18.


  2. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on influenza vaccination: continued use of Fluviral influenza vaccine in the 2000-2001 season  Can.Commun.Dis.Rep.  1-15-2001, 27 (15-16): 1-3.


  3. Ball, R., Ball, L. K., Wise, R. P., Braun, M. M., Beeler, J. A., and Salive, M. E. 
    Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system  Pediatr.Infect.Dis.J.  2001, 20 (2): 219-223.


  4. Breithaupt, T., Harris, K., Ellis, J., Purcell, E., Weir, J., Clothier, M., and Boesler, D. 
    Thoracic lymphatic pumping and the efficacy of influenza vaccination in healthy young and elderly populations  J.Am.Osteopath.Assoc.  2001, 101 (1): 21-25.


  5. Brydak, L. B., Roszkowska-Blaim, M., Machala, M., Leszczy&nacute, ska, B., and Sieniawska, M. 
    Immunological response to influenza vaccination in children with renal failure  Nephrol.Dial.Transplant.  2001, 16 (3): 643-644.


  6. de Moraes, Jd, Barata, R., Ribeiro, M. C., and de Castro, P. C. 
    [Vaccination coverage in the first year of life in 4 cities of the state of Sao Paulo, Brazil]  Rev.Panam.Salud Publica.  2000, 8 (5): 332-341.
    Keywords: BCG Vaccine/administration & dosage/Brazil/Cohort Studies/Diphtheria-Tetanus-Pertussis Vaccine/Health Care Surveys/Health Services Needs and Demand/statistics & numerical data/Human/Immunization Programs/Infant/Infant,Newborn/Measles/prevention & control/Poliomyelitis/Rubella/Socioeconomic Factors/Statistics/Support,Non-U.S.Gov't/Vaccination/utilization


  7. de Swart, R. L., El Mubarak, H. S., Vos, H. W., Mustafa, O. M., Abdallah, A., Groen, J., Mukhtar, M. M., Zijlstra, E. E., El Hassan, A. M., Wild, T. F., Ibrahim, S. A., and Osterhaus, A. D. 
    Prevention of measles in Sudan: a prospective study on vaccination, diagnosis and epidemiology  Vaccine.  3-21-2001, 19 (17-19): 2254-2257.


  8. del Rey, Calero J. 
    [Current interest of antipneumococcal vaccination]  An R.Acad.Nac.Med.(Madr.).  2000, 117 (1): 163-178.
    Keywords: Adult/Antibiotics/therapeutic use/Child/Community-Acquired Infections/epidemiology/microbiology/prevention & control/Drug Resistance,Microbial/Human/Pneumococcal Vaccines/Pneumonia,Bacterial/Pneumonia,Pneumococcal/Spain


  9. DeWilde, S., Carey, I. M., Richards, N., Hilton, S. R., and Cook, D. G. 
    Do children who become autistic consult more often after MMR vaccination?  Br.J.Gen.Pract.  2001, 51 (464): 226-227.


  10. El Kasmi, K. C. and Muller, C. P. 
    New strategies for closing the gap of measles susceptibility in infants: towards vaccines compatible with current vaccination schedules  Vaccine.  3-21-2001, 19 (17-19): 2238-2244.


  11. Handjani, F., Delir, S., Sodaifi, M., and Kumar, P. V. 
    Lupus vulgaris following bacille Calmette-Guerin vaccination  Br.J.Dermatol.  2001, 144 (2): 444-445.


  12. Hanke, W. 
    [Efficacy of vaccination against influenza among working people--results of epidemiological studies]  Med.Pr.  2000, 51 (5): 475-484.
    Keywords: Canada/epidemiology/Cost Control/Disease Outbreaks/prevention & control/Employment/statistics & numerical data/Health Promotion/Human/Influenza/Influenza Vaccine/immunology/Poland/Sick Leave/economics


  13. Ii, M. and Ohkusa, Y. 
    [An empirical research for demand of influenza vaccination]  Nippon Koshu Eisei Zasshi.  2001, 48 (1): 16-27.


  14. Jacobson, R. M., Adegbenro, A., Pankratz, V. S., and Poland, G. A. 
    Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study  Vaccine.  3-21-2001, 19 (17-19): 2428-2433.


  15. Kramarz, P., Destefano, F., Gargiullo, P. M., Chen, R. T., Lieu, T. A., Davis, R. L., Mullooly, J. P., Black, S. B., Shinefield, H. R., Bohlke, K., Ward, J. I., and Marcy, S. M. 
    Does influenza vaccination prevent asthma exacerbations in children?  J.Pediatr.  2001, 138 (3): 306-310.


  16. Lagrange, P. H. 
    [Vaccinations. Immunological and microbiological bases, indications, contra-indications, adverse effects, efficacy (schedule and mandatory character of excluded vaccinations]  Rev.Prat.  12-15-2000, 50 (20): 2275-2283.
    Keywords: Adult/Child/Human/Immunization Schedule/Vaccination/adverse effects/classification/contraindications/methods/Vaccines/administration & dosage/immunology


  17. LeBaron, C. W., Massoudi, M., Stevenson, J., and Lyons, B. 
    Vaccination coverage and physician distribution in the united states, 1997  Pediatrics.  2001, 107 (3): E31.


  18. Lehtinen, M., Dillner, J., and Paavonen, J. 
    Vaccinating women against premature death: summary of an International Workshop, Helsinki, Finland, 10.01.2000  Vaccine.  1-8-2001, 19 (11-12): 1347-1352.


  19. Nichol, K. L. 
    Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza  Arch.Intern.Med.  3-12-2001, 161 (5): 749-759.


  20. Nicolay, U., Girgsdies, O. E., Banzhoff, A., Hundt, E., Kondler-Budde, R., Lober, R., Hainz, R., and Jilg, W. 
    [Diphtheria antitoxin level 2 years after booster vaccination]  Wien.Med.Wochenschr.  2000, 150 (22): 435-439.
    Keywords: Adolescence/Adult/Comparative Study/Diphtheria/immunology/prevention & control/Diphtheria Antitoxin/blood/Diphtheria Toxoid/administration & dosage/English Abstract/Female/Human/Immunization Schedule/Immunization,Secondary/Male/Middle Age/Prospective Studies


  21. Olson, A. D., Shope, T. C., and Flynn, J. T. 
    Pretransplant varicella vaccination is cost-effective in pediatric renal transplantation  Pediatr.Transplant.  2001, 5 (1): 44-50.


  22. Pareek, M. and Pattison, H. M. 
    The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate  Br.J.Gen.Pract.  2000, 50 (461): 969-971.
    Keywords: Attitude to Health/Child,Preschool/Cohort Studies/Cross-Sectional Studies/England/Female/Human/Immunization Programs/utilization/Infant/Measles/prevention & control/Measles-Mumps-Rubella Vaccine/administration & dosage/adverse effects/Mothers/psychology/Mumps/Patient Acceptance of Health Care/statistics & numerical data/Prospective Studies/Rubella/Social Class/Support,Non-U.S.Gov't


  23. Quast, U. and Maass, G. 
    [Vaccination record. Patient data series]  MMW.Fortschr.Med.  12-7-2000, 142 (49-50): 50-52.
    Keywords: Adolescence/Adult/Child/Child,Preschool/Data Collection/statistics & numerical data/Germany/Human/Immunization Programs/Infant/Medical Records/Vaccination


  24. Reichert, T. A., Sugaya, N., Fedson, D. S., Glezen, W. P., Simonsen, L., and Tashiro, M. 
    The Japanese experience with vaccinating schoolchildren against influenza  N.Engl.J.Med.  3-22-2001, 344 (12): 889-896.


  25. Roos-Van Eijndhoven, D. G., Cools, H. J., Westendorp, R. G., Cate-Hoek, A. J., Knook, D. L., and Remarque, E. J. 
    Randomized controlled trial of seroresponses to double dose and booster influenza vaccination in frail elderly subjects  J.Med.Virol.  2001, 63 (4): 293-298.


  26. Salleras, L., Dominguez, A., Prats, G., Parron, I., and Munoz, P. 
    Dramatic decline of serogroup C meningococcal disease incidence in Catalonia (Spain) 24 months after a mass vaccination programme of children and young people  J.Epidemiol.Community Health.  2001, 55 (4): 283-287.


  27. Shadick, N. A., Liang, M. H., Phillips, C. B., Fossel, K., and Kuntz, K. M. 
    The Cost-effectiveness of Vaccination Against Lyme Disease  Arch.Intern.Med.  2-26-2001, 161 (4): 554-561.


  28. Sheikh, N. A., al Shamisi, M., and Morrow, W. J. 
    Delivery systems for molecular vaccination  Curr.Opin.Mol.Ther.  2000, 2 (1): 37-54.


  29. Smeeth, L., Hall, A. J., Fombonne, E., Rodrigues, L. C., Huang, X., and Smith, P. G. 
    A case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology  BMC.Public Health.  2001, 1 (1): 2.


  30. Vlasich, C. 
    Pneumococcal infection and vaccination in the elderly  Vaccine.  3-21-2001, 19 (17-19): 2233-2237.

Back to Top